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Retinitis pigmentosa (RP) is the most common inherited retinal disease characterized
by progressive degeneration of photoreceptors and/or retinal pigment epithelium that
eventually results in blindness. Mutations in pre-mRNA processing factors (PRPF3, 4,
6, 8, 31, SNRNP200, and RP9) have been linked to 15–20% of autosomal dominant
RP (adRP) cases. Current evidence indicates that PRPF mutations cause retinal specific
global spliceosome dysregulation, leading to mis-splicing of numerous genes that are
involved in a variety of retina-specific functions and/or general biological processes,
including phototransduction, retinol metabolism, photoreceptor disk morphogenesis,
retinal cell polarity, ciliogenesis, cytoskeleton and tight junction organization, waste
disposal, inflammation, and apoptosis. Importantly, additional PRPF functions beyond
RNA splicing have been documented recently, suggesting a more complex mechanism
underlying PRPF-RPs driven disease pathogenesis. The current review focuses on the
key RP-PRPF genes, depicting the current understanding of their roles in RNA splicing,
impact of their mutations on retinal cell’s transcriptome and phenome, discussed in the
context of model species including yeast, zebrafish, and mice. Importantly, information
on PRPF functions beyond RNA splicing are discussed, aiming at a holistic investigation
of PRPF-RP pathogenesis. Finally, work performed in human patient-specific lab models
and developing gene and cell-based replacement therapies for the treatment of PRPF-
RPs are thoroughly discussed to allow the reader to get a deeper understanding of
the disease mechanisms, which we believe will facilitate the establishment of novel and
better therapeutic strategies for PRPF-RP patients.
Keywords: retinitis pigmentosa, pre-mRNA processing factor, spliceosome, gene therapy, splicing, animal
models, circadian rhythm, DNA damage and repair
INTRODUCTION
Retinitis pigmentosa (RP) is the most common group of inherited retinal disorders characterized by
progressive degeneration of photoreceptors and/or the retinal pigment epithelium (RPE). Most RP
cases start with night blindness due to the breakdown of rod photoreceptors, which are responsible
for night vision. As the disease progresses, mid-peripheral vision is lost (tunnel vision), followed
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by cone degeneration leading to central vision loss until eventual
blindness (Hartong et al., 2006; Berger et al., 2010). The
prevalence of RP is around 1 in 4000 and there are over
1.5 million people suffering from this condition worldwide
(Verbakel et al., 2018). There is no cure for RP although
vitamins, nutritional supplementation and small molecules may
slow disease progression.
To date, more than 70 genetic loci have been involved in
the pathogenesis of RP1. Approximately half of RP cases have
previous family history and fall into three Mendelian modes
of inheritance: autosomal recessive (arRP), autosomal dominant
(adRP), and X-linked recessive (xlRP) (Hamel, 2006). 50–60%
of RP cases are caused by autosomal-recessive inheritance, 30–
40% of cases are autosomal dominant, and 5–15% of cases
are X-linked. Most of the genes involved in RP ontology are
expressed specifically in the retina and/or RPE and contribute
to photoreceptor or RPE function. Mutations in the rhodopsin
(RHO) gene are the most common cause of adRP accounting
for 25% of adRP cases. Interestingly, the second most common
cause of adRP accounting for 15–20% of adRP cases, is linked to
mutations in the ubiquitously expressed pre-mRNA processing
factor (PRPF) genes, that encode core components of the
spliceosome (Wang et al., 2019).
Pre-mRNA splicing is the process which removes introns
and ligates exons to form mature mRNA molecules. Splicing
occurs in a large RNA-protein complex called spliceosome that
is composed of five small nuclear ribonucleoproteins (snRNPs)
namely U1, U2, U4, U5, and U6 and approximately 200
additional factors (Wang et al., 2015). The U1 and U2 snRNPs,
respectively, bind to pre-mRNA intronic 5′-splice site and
branch point site to form complex A followed by recruitment
of the U4/U6.U5 tri-snRNP complex to form the precatalytic
spliceosome (complex B). Next U1 and U4 snRNPs are released
from the spliceosome by the action of RNA helicases PRPF28
and SNRNP200 forming the activated spliceosome (Bact), which
is then converted to the catalytically activated spliceosome (B∗)
that catalyzes two steps of trans-esterification reactions, in a
stepwise manner, to complete pre-mRNA splicing (Shi, 2017;
Figure 1). PRPFs are essential components of tri-snRNP and are
critical for the assembly of mature splicing complex. Mutations
in seven PRPF genes have been identified in adRP, including
PRPF3, 4, 6, 8, 31, SNRNP200 (Brr2), and RP9 (PAP-1) (Mordes
et al., 2006; Chen et al., 2014; Daiger et al., 2014; Ruzickova
and Stanek, 2017), all of which except RP9 encode components
of tri-snRNP and play important roles in the assembly of
spliceosome complex B. During spliceosome assembly, U4 and
U6 snRNP strongly bind with each other via snRNA paring to
form U4/U6 di-snRNP which subsequently associates with U5
snRNP leading to U4/U6.U5 tri-snRNP conformation (Nguyen
et al., 2015). Amongst the seven RP-PRPF proteins, PRPF3,
PRPF4, and PRPF31 are U4/U6 snRNP-specific factors, while
PRPF6, PRPF8, and SNRNP200 are components of U5 snRNP
and RP9 is a non-snRNP splicing factor (Liu et al., 2006;
Supplementary Table 1).
1https://sph.uth.edu/retnet/home.htm
The interactions among PRPFs and PRPF-snRNA crosslinks
within tri-snRNP have been well described in other reviews
(Abovich et al., 1990; Makarov et al., 2000; Gonzalez-Santos et al.,
2002; Kuhn et al., 2002; Makarova et al., 2002; Nottrott et al.,
2002; Schaffert et al., 2004; Liu et al., 2006). Moreover, recent yeast
and human cryo-EM structures of spliceosomes at different stages
of splicing have shed light on the RNA and protein structural
rearrangements of the spliceosome during splicing cycle. Figure 2
shows a snapshot of the human spliceosome complex B after the
release of U1 snRNP. Hotspots for RP mutations within PRPF
structures are depicted with red spheres. Of note, most of these
mutations are in domains associated with RNA binding (e.g., in
SNRNP200’s U4 snRNA binding channel).
PRPFs are ubiquitously expressed and mutations in RP-PRPF
genes disrupt spliceosome assembly, leading to faulty splicing
(Tanackovic et al., 2011b). However, the mutations appear to
be tolerated by the majority of human tissues yet cause non-
syndromic RP restricted to the eye. Although the molecular
mechanisms underlying this phenomenon remain unclear,
several models have been proposed to explain the photoreceptor-
specific phenotype. Haploinsufficiency, dominant-negative and
gain-of-function are all implicated in the pathogenesis of PRPF-
RPs (Mordes et al., 2006). As one of the most metabolically
active tissues, retina has the highest level of steady state
snRNAs and processed pre-mRNAs, indicating the requirement
of a higher splicing activity compared to other tissues
(Tanackovic et al., 2011b). Thus, the disrupted RNA splicing
activity due to PRPF mutations is more likely to impair
retinal cell functions or viability than other tissues. Using
a patient-specific cell model, our research revealed that
PRPF31 mutations induce retinal-specific global spliceosome
dysregulation, resulting in mis-splicing and/or differential
expression of a subset of genes that play essential roles in
retina and RPE cells (Buskin et al., 2018). Aside from their
roles in RNA splicing, PRPFs have recently been implicated
in photoreceptor ciliogenesis, circadian regulation, and DNA
damage repair, suggesting a possible model in which PRPF
mutations impair crucial retinal functions and contribute to RP
development. These extra-spliceosome functions of PRPFs will
provide a new perspective on the relationship between distinct
RP symptoms and mutations in the ubiquitously expressed
splicing factors.
In this manuscript, we review PRPF mutations responsible for
RP pathogenesis and their role in both splicing and other cellular
processes. Disease modeling of PRPF-RP in various species is
also discussed to provide more details on RP pathogenesis and
development of therapies for PRPF-RP.
PRPF MUTATIONS IMPLICATED IN RP
PATHOGENESIS
Of all the seven splicing factors, PRPF31 is the most prominent
adRP related gene, whose mutations account for 8.9% of all
cases, followed by PRPF8 (2.6%), SNRNP200 (1.6%), PRPF3
(1.5%) and PRPF4, PRPF6, and RP9, which are responsible for
a small proportion of adRP occurrence (Bowne et al., 2013;
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FIGURE 1 | Schematic illustration showing the process of pre-mRNA splicing cycle.
Daiger et al., 2014). Homozygous knockout or mutation of RP-
Prpf genes is embryonic lethal to animal models (Bujakowska
et al., 2009; Linder et al., 2014), implying that these splicing
factors are essential for early embryonic development and
survival. Heterozygous depletion or mutation of RP-Prpf genes
lead to development of RP phenotype through loss-of-function
and/or dominant-negative effects (Supplementary Table 1).
Below we review the types of PRPF mutations involved in RP.
The PRPF3 gene is located on chromosome 1q21.2. The
encoded PRPF3 protein is an essential component of U4/U6
snRNP that binds U6 snRNA (Liu et al., 2006, 2015). In
the spliceosome B complex, PRPF3 interacts with PRPF4
and PRPF6 and stabilizes U4/U6.U5 tri-snRNP (Figure 2).
PRPF3 inactivation compromises spliceosome assembly due to
the absence of intact U4/U6.U5 tri-snRNPs (Anthony et al.,
1997; Heng et al., 1998; Liu et al., 2006). Heterozygous
mutations in the PRPF3 gene lead to RP type 18 (RP18). The
implication of PRPF3 mutation in adRP was first reported by
Chakarova et al. (2002). To date, 10 PRPF3 mutations have been
identified in RP18 families (Chakarova et al., 2002; Amsterdam
et al., 2004; Comitato et al., 2007; Gamundi et al., 2008;
Graziotto et al., 2008, 2011; Zhong et al., 2016). Eight missense
PRPF3 mutations identified in adRP families are clustered at
the highly conserved C-terminal domain for binding to U4/U6
snRNA and splicing factors including PRPF4, PRPF6, p110,
SPF30, Hsnu66, and RP9 (Chakarova et al., 2002; Maita et al.,
2005; Gamundi et al., 2008; Cao et al., 2011; Zhong et al.,
2016). Thr494Met is the most common mutation that is observed
frequently in unlinked families worldwide. Thr494Met mutation
substantially reduces the phosphorylation of PRPF3 C-terminal
region by casein kinase II, thereby suppressing its association
with itself, Hprp4p, and U4/U6 snRNA (Gonzalez-Santos et al.,
2008). RP18 patient lymphoblast cell lines with mutated PRPF3
showed altered levels of snRNPs, delayed spliceosome assembly
and decreased splicing efficiency (Tanackovic et al., 2011b).
The PRPF4 gene is located on chromosome 9q32, which
encodes a protein associated with RP type 70 (RP70) (Heng
et al., 1998). At the entire C-terminal portion of PRPF4 protein,
there are 7 WD40 domain repeats that act as protein interaction
scaffolds in multiprotein complexes. PRPF4 protein interacts
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FIGURE 2 | Schematic diagram illustrating the structures of spliceosome complex B and tri-snRNP. (A) Composition of complex B; (B) cryo-EM structure of
pre-catalytic spliceosome complex B with RP-linked PRPFs highlighted. The pre-mRNA, U4, and U6 snRNAs are colored brown, magenta, and orange, respectively.
Six PRPFs, which are core components of tri-snRNP, are labelled and color-coded. Residues mutated in RP are shown as red spheres. The PRPF8 Jab1 domain is
labelled. The image was created using PyMol (DeLano, 2002).
directly with PRPF3 in U4/U6 and U4/U6.U5 snRNPs to play
important roles in spliceosome assembly (Anthony et al., 1997;
Wang et al., 1997). The link between PRPF4 mutations and
RP was first identified in two labs in 2014 (Chen et al.,
2014; Linder et al., 2014). Chen et al. (2014) identified two
heterozygous mutations in PRPF4 in a simplex RP patient
and an adRP family. The mutation c.-114_-97del disrupts the
binding sites for two transcription factors c-Ets-1 and GR-alpha
in ARPE19 and 293T cells and dramatically suppresses the
expression of PRPF4. Interestingly, in RP patient cells with PRPF4
c.944C > T (p.Pro315Leu) mutation, tri-snRNP component
genes are upregulated, indicating a compensatory response
to PRPF4 dysfunction. In addition, both the wild type and
mutant PRPF4 are upregulated, implicating a dominant-negative
effect. In 2014, Linder et al. reported another RP associated
PRPF4 mutation c.575G > A (p.Arg192His) that interrupts the
interaction between PRPF4 and PRPF3 and incorporation of
PRPF4 into tri-snRNP in Hela and Hek293 cells. Loss-of-function
rather than dominant-negative effect was suggested as the main
mechanism underlying Arg192His mutation related RP (Linder
et al., 2014). There are currently 5 PRPF4 mutations identified.
The PRPF6 gene is located on chromosome 20q13.33
that encodes PRPF6 protein associated with RP type 60
(RP60). PRPF6 protein contains tetratrico peptide repeats (TPR)
domains in the C-terminal region that mediates protein-protein
interactions and the formation of multiprotein complexes. As
a U5 specific protein, PRPF6 serves as a scaffold bridging U5
and U4/U6 snRNPs (Figure 1) during the assembly of tri-
snRNPs (Makarov et al., 2000). With PRPF6 mutation, tri-
snRNP accumulation is suppressed (Galisson and Legrain, 1993).
Tanackovic et al. (2011a) first identified a PRPF6 missense
mutation, c.2185C > T (p.Arg729Trp) that was co-segregated
with adRP in an affected family. PRPF6 mutant protein displays
abnormal localization in Cajal bodies within nuclei in Hela
cells, where immature snRNP complexes accumulate, indicating
an impairment in tri-snRNP assembly or recycling (Schaffert
et al., 2004). In addition, RP patient lymphoblasts containing
p.Arg729Trp mutation in PRPF6 displayed defective pre-mRNA
splicing capacity with signature introns retained, indicating an
inefficient spliceosome (Tanackovic et al., 2011a). 18 PRPF6
mutations have been identified till now.
The PRPF31 gene is located on chromosome 19q13.42. The
encoded pre-mRNA processing factor is linked to adRP type 11
(RP11). PRPF31 is a U4/U6 specific protein that binds directly to
U4 snRNA (Figure 1; Nottrott et al., 2002). PRPF31 interacts with
PRPF6 and tethers U5 snRNP to the U4/U6 snRNP facilitating
the formation of tri-snRNPs (Makarova et al., 2002). PRPF31
contains a Nop domain that mediates protein-RNA interactions
(Liu et al., 2007). The knockdown of PRPF31 by RNAi results
in the interruption of U5 and U4/U6 snRNP interaction
and inhibition of tri-snRNP formation, demonstrating an
essential role of PRPF31 in tri-snRNPs assembly. Similar to
PRPF6 depletion, PRPF31 knockdown in Hela cells, leads to
accumulation of U4/U6 di-snRNPs in subnuclear organelle
Cajal bodies, but U5 snRNPs largely remain in nucleoplasmic
speckles (Schaffert et al., 2004). Deletion of the PRPF31 gene
in yeast inhibits tri-snRNP assembly and blocks pre-mRNA
splicing (Weidenhammer et al., 1996, Weidenhammer et al.,
1997). The first RP-related PRPF31 mutation was reported by
Vithana et al. (2001). To date, 229 PRPF31 mutations of various
types have been identified in RP11 families and sporadic cases,
including missense/nonsense substitution, deletion, insertion,
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frameshift, premature stop codon and intron splice site mutation
etc. (Mordes et al., 2006; Ruzickova and Stanek, 2017)2. These
mutations result in alteration of sequence and structure of
the PRPF31 protein or a decreased level due to impacts
on transcription and pre-mature mRNA/protein degradation,
leading to functional defects, haploinsufficiency and dominant-
negative effects (Vithana et al., 2001; Martinez-Gimeno et al.,
2003; Wang et al., 2003; Xia et al., 2004; Wilkie et al., 2008).
The PRPF8 gene is located on chromosome 17p13.3 associated
with RP type 13 (RP13). The encoded PRPF8 protein is the
largest and most highly conserved spliceosome component that
plays critical roles in pre-mRNA splicing as core component of
precatalytic, catalytic and post-catalytic spliceosomal complexes
during the splicing cycle (Achsel et al., 1998; Grainger and
Beggs, 2005). PRPF8 protein serves as a scaffold to mediate the
assembly of U4/U6.U5 tri-snRNP and positions U2, U5, and U6
snRNAs at splice sites on pre-mRNA substrates. PRPF8 binds
to 5′ splice site, branch point and 3′ splice site of pre-mRNA as
well as U5 and U6 snRNAs. Immunoprecipitation experiments
have revealed the association of PRPF8 with pre-mRNA, lariat
intermediate, lariat product, and ligated exons (Luo et al.,
1999). A Jab1/MPN domain resides in the C-terminal region of
PRPF8, which interacts with the SNRNP200 helicase to regulate
U4/U6 snRNA duplex unwinding during B complex activation
(Maeder et al., 2009; Mozaffari-Jovin et al., 2012, 2013; Nguyen
et al., 2013). In adRP cells, mutant PRPF8 protein displays
less effective interaction with SNRNP200, defective splicing
site recognition, and U4/U6 unwinding, affecting spliceosome
assembly, which contributes to suppression of splicing efficiency
(Tanackovic et al., 2011b; Wickramasinghe et al., 2015; Mayerle
and Guthrie, 2016). Mutations in PRPF8 have been implicated
in the development of adRP and primary open angle glaucoma
(POAG) (Tarttelin et al., 1996; Gamundi et al., 2008; Walia
et al., 2008; Towns et al., 2010; Micheal et al., 2018). The co-
segregation of PRPF8 mutations with adRP was first revealed in
2001 (McKie et al., 2001). To date, 64 PRPF8 mutations have been
reported (see footnote 2), including missense/nonsense, small
deletion, small insertion, small indel, gross deletion. Notably,
most of the mutations cluster in PRPF8 C-terminal region, which
contains functional domains that are related to interaction with
pre-mRNA 5′ splice site, interaction with the RNA helicase
SNRNP200 and GTPase EFTUD2 (HSNU114). Thus, PRPF8
mutations can lead to multiple defects in spliceosome assembly
and activation during pre-mRNA splicing. In contrast to PRPF31,
both the wild type and mutant alleles in RP13 cell lines with a
nonsense mutation displayed comparable expression of PRPF8,
suggesting that haploinsufficiency is not the cause of PRPF8-RP
(Gamundi et al., 2008).
DISEASE MODELS FOR PRPF-RPs
Since the first observation of pre-mRNA splicing reaction
in Berget et al. (1977), a variety of cellular and animal
models have been adopted for the investigation of spliceosome
2https://my.qiagendigitalinsights.com/bbp/view/hgmd/pro/start.php
machinery, disease-related splicing defects and therapeutic
studies. From single-celled yeast to metazoan Caenorhabditis
elegans and mammalian systems such as mice and non-
human primates, exquisitely designed laboratory models have
substantially expanded our knowledge on the mechanisms
unpinning RNA splicing. These are discussed as follows:
Yeast Models
RNA splicing remains highly conserved during evolution. In
yeast and metazoans, spliceosome assembly and RNA splicing
reaction steps are similar, so the investigations of RNA splicing
factors in yeast can be generalized to multicellular eukaryotic
organisms including humans (Anderson et al., 1989; Hossain
and Johnson, 2014). Saccharomyces cerevisiae exists stably as
both haploid and diploid cells and two haploid cells mate to
form a single diploid cell. Based on this important feature,
the yeast two-hybrid system provides a powerful tool for the
study of spliceosome conformation and the interaction among
components (Liu et al., 2006). In addition to the yeast two-
hybrid system, co-immunoprecipitation, isothermal titration
calorimetry, biochemical complementation assay, synthetic
lethality assay etc. provide additional assays for validation of
potential interactions between components of the spliceosome.
Screening of temperature-sensitive yeast mutants using the
intron-containing CRY1 and ACT1 genes as hybridization probes
is widely used for identification of pre-mRNA splicing defects
and related splicing factors (Lustig et al., 1986; Warner, 1987;
Maddock et al., 1996; Noble and Guthrie, 1996). In S. cerevisiae
more than 30 gene products have been identified as essential for
RNA splicing which are referred to as precursor RNA processing
proteins (PRPs) including orthologs of all human pre-mRNA
processing factors responsible for RP (Weidenhammer et al.,
1996; Faustino and Cooper, 2003).
PRP3 is the yeast homolog of PRPF3. PRP3 mutant was
identified in a screen of temperature-sensitive yeast strains
with accumulation of unspliced pre-mRNAs, indicating the
blockage of spliceosome assembly due to dysfunction of Prp3
protein (Anthony et al., 1997). The temperature sensitive
mutation of the PRP3 gene was rescued by extra copies
of the wild type PRP4 gene (Hu et al., 1994); however, a
double mutant of PRP4 and PRP3 exhibited synthetic lethality
(Wang et al., 1997). The biochemical complementation and
synthetic lethality by PRP3 and PRP4 mutations corroborate
their interaction in U4/U6 snRNP. The deletion of 5′ stem-
loop in U4 snRNA inhibits the Prp4-snRNA interaction and
suppresses the formation of U4/U6.U5 tri-snRNP, indicating
the important roles of Prp4 protein and this region of the U4
snRNA in spliceosome assembly (Bordonne et al., 1990). Human
PRPF6 homolog Prp6 in yeast functions in the same way as
its counterpart in mammalian cells to bridge the association
between U4/U6 snRNP and U5 snRNP. A temperature-sensitive
strain carrying mutations at PRP6 locus displayed inactivated
RNA splicing at 37◦C (Abovich et al., 1990). By temperature-
sensitive screening of splicing defective yeast strains, PRPF31
ortholog PRP31 was identified and shown to be important
for cell viability (Maddock et al., 1996). PRP31 mutant yeast
strain is defective in splicing in vitro as well as in vivo,
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indicating the direct contribution of Prp31 to splicing pathway
(Weidenhammer et al., 1997).
Prp8/PRPF8 is a highly conserved pre-mRNA splicing factor
from yeast to man. Yeast two-hybrid system assays have
confirmed the interaction between Prp8 and Brr2 (the yeast
homolog of the human RNA helicase SNRNP200), which
is interrupted by RP mutations in the C-terminus of Prp8
protein (van Nues and Beggs, 2001; Pena et al., 2007). Yeast
strains with PRP8-depletion, inactivation or introduction of RP-
causing mutations display temperature sensitivity and reduced
growth rate. The impaired Prp8 function inhibits spliceosome
assembly, causing severe splicing defect and abnormal alternative
splicing profile (Jia and Sun, 2018). Boon et al. (2007)
revealed a U5 snRNP precursor in the cytoplasmic containing
Prp8-Aar2 interaction that is converted to Prp8-Brr2 when
imported into the nucleus to become mature snRNP complex
(Weber et al., 2013). The PRP8-RP mutation disrupts the
Prp8–Brr2 interaction, thereby reducing the functional U5
snRNP and U4/U6.U5 tri-snRNP formation in the nucleus
(Mozaffari-Jovin et al., 2013). Furthermore, high-throughput
screening with temperature-sensitive yeast mutant strains in
search of therapeutic compounds or target genes/proteins
identified Srn1 as a suppressor of the defects caused by
several of the PRP mutants (Pearson et al., 1982). While
Spp81 was identified as suppressor of PRP8 mutation (Jamieson
et al., 1991). And the pharmacological chaperone, 9-cis retinal,
could partially rescue light-dependent activation of a disease-
associated rhodopsin mutation (Pro23His) expressed in yeast
(Scott et al., 2019).
Taken together, the yeast system is ideal for the screening of
splicing factors, the study of interactions between spliceosome
components and the effects of splicing factor mutations on
spliceosome assembly and RNA splicing reactions. However,
the characteristics of the yeast cells differ significantly from the
human retinal cells and are thus unable to fully mimic the
PRPF-RP disease phenotypes.
Zebrafish Models
Being a vertebrate metazoan, zebrafish has major tissues and
organs including eyes with similar characteristics to humans,
and as such proven to be an excellent model for developmental
and disease studies. Adult zebrafish breed approximately every
10 days and can produce 50–300 eggs at a time, providing many
experimental specimens in a short period of time. Zebrafish
embryos develop externally and are nearly transparent, making
microscopic examination easy. With fertilized eggs at the one-
cell-stage, genetic modification can be easily achieved through
microinjection of DNA or RNA (Zheng et al., 2018). The
zebrafish genome has been fully sequenced and shares 70%
of genes with human, and more than 80% of the disease-
related human genes have their zebrafish counterparts (Howe
et al., 2013). RP-associated prpf genes have been modulated in
zebrafish as animal models for the study of RP pathogenesis
and drug screening.
Homozygous prpf3 knockout is lethal to zebrafish, resulting
in death at 4 days post fertilization. Within the knockout
embryos, elevated cell death level occurs in the developing eyes.
However, no developmental abnormality or retinal degeneration
is observed in the heterozygous prpf3 knockout zebrafish,
suggesting that RP18 is caused by toxic gain of function by
missense mutations in prpf3 rather than haploinsufficiency
(Amsterdam et al., 2004; Graziotto et al., 2008).
Prpf4 knockdown in zebrafish results in photoreceptor
morphology alteration and degeneration (Linder et al., 2014). The
mutation of c.575 G > A (p.R192H) in the zebrafish homolog
of prpf4 gene disrupts the interaction between prpf4 and prpf3
and interferes with the integration of prpf4 into the tri-snRNP
and spliceosome (Linder et al., 2014). The introduction of prpf4
c.944C > T (Pro315Leu) missense mutation in zebrafish leads
to systemic deformation of larvae including malformed brains,
short trunks, cardiac edema, and curved body axis as well
as disrupted photoreceptor inner and outer segment structure
and compromised rhodopsin reactivity (Chen et al., 2014). Co-
injection of prpf4 c.944C > T and morpholino oligos (MOs)
against prpf4 in zebrafish significantly increases embryo death
rate, indicating that c.944C > T acts as a dominant-negative
mutation in the morphant that competes the residual function
of wild type zebrafish Prpf4 protein. Notably, several retinal
transcripts are downregulated by prpf4 c.944C > T mutation,
implicating the molecular mechanism of RP70 associated with
prpf4 mutation.
Prpf31 protein is essential for zebrafish embryonic survival
and eye development. Prpf31 silencing by morpholino
oligonucleotides (MOs) results in severe embryonic
malformations and lethality. Knockdown of prpf31 primarily
affects retinal photoreceptor outer segments and impairs visual
function showing substantially decreased optokinetic nystagmus
(OKN), and in severe cases there are no saccadic movements
(Linder et al., 2011). Gene expression analysis reveals that a set
of retinal genes, such as rho, gnat2, and pde6c, are selectively
downregulated in prpf31 morphants and this may cause the
retina-specific phenotype. Two RP-related mutations in prpf31,
SP117 (c.769insA) and AD5 (c.1115_1125 del) were introduced
into zebrafish (Yin et al., 2011). Both mutations led to instability
of the mutant proteins. SP117 (c.769insA) displayed aberrant
cytoplasm localization in rod photoreceptors, however rod
morphology or numbers were not affected. Injection of SP117
(c.769insA) mutant mRNA into zebrafish embryos neither
rescued the prpf31 morphant phenotype nor increased the
degeneration of photoreceptors, suggesting haploinsufficiency
could be the underlying mechanism in human RP patients
carrying SP117 (c.769insA) mutations. AD5 (c.1115_1125
del) mRNA injection led to embryonic malformations and
dose-dependent lethality. Retinas expressing AD5 (c.1115_1125
del) displayed loss of the outer segments, disintegrated nuclei,
and increased apoptosis in rod photoreceptors. The wild type
prpf31 mRNA rescued the embryonic lethality induced by AD5
(c.1115_1125 del), however, AD5 (c.1115_1125 del) mutant
RNA was not able to rescue the prpf31 morphant phenotype, but
instead aggravated the MO phenotypes, indicating that AD5 acts
in a dominant-negative fashion in RP pathogenesis. Expression
of phototransduction-related genes were down-regulated in
AD5 expressing retinas, including rho, gnat1, guk1, rcv1, calb2,
which display significantly stabilized introns, suggesting the
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disrupted mRNA splicing by AD5 mutation as a cause of
photoreceptor dysfunction.
Mouse Models
Mice are evolutionarily more like humans, because they are
mammals, and therefore normally used as models of human
diseases. Homozygous/heterozygous knock-in/knockout mouse
models provide platforms for comparative studies to elucidate the
pathogenic mechanisms of Prpf mutations associated RPs.
Homozygous Prpf3 and Prpf31 knockout are lethal to the
mouse embryo, while no photoreceptor degeneration or retinal
dysfunction is observed with heterozygous knockout mice
(Graziotto et al., 2008; Bujakowska et al., 2009). Transgenic
mice with Prpf3T 494M/+ and Prpf8H2309P/+ mutations display
late-onset RPE degenerative morphologies, including loss of
basal infoldings, accumulation of amorphous deposits beneath
the RPE, and vacuolization in the cytoplasm. These RPE
abnormalities are more severe in the homozygous Prpf3-T494M
and Prpf8-H2309P mice, suggesting that RP18 and RP13 are
caused by the gain-of-function or dominant-negative effect
of Prpf3 and Prpf8 mutations (Graziotto et al., 2011; Farkas
et al., 2014). Such phenotypes are also observed in Prpf31±
knockout mice. Moreover, transfection of truncated Prpf31
mutants N371 or N256 into primary mouse retinal culture cells
leads to significant apoptosis (Yuan et al., 2005). Thereby, both
haploinsufficiency and dominant-negative effects are likely to
underly the pathogenic mechanism of Prpf31 mutations. Daily
phagocytosis of shed photoreceptor outer segments (POS) is
one of the key functions of RPE (Kevany and Palczewski,
2010). The Prpf31± mutant RPE cells show remarkably
reduced phagocytosis, demonstrated by declined phagocytic peak
intensity and altered diurnal rhythmicity, attenuated phagocytic
burst after light onset, and spreading of the phagocytic peak time.
The adhesion between the RPE apical microvilli and the POS
is significantly reduced, suggesting disturbance of the integral
function of the neural retina and RPE. Additionally, Prpf mutant
mouse models display mis-localization of the major phagocytic
receptors avβ5 integrin, MerTK and signaling protein FAK as
well as MerTK ligand GAS6, both located on the apical surface
of wild type RPE (Finnemann et al., 1997; Finnemann, 2003;
Mao and Finnemann, 2012). Despite the morphological changes
and functional deficiencies in mutant RPE, the photoreceptor
cells in the mutant mice appear to be normal in histological and
ultrastructural analyses and only at 24 months, the Prpf3T 494M
mice show decreased maximal rod a- and b-waves, but with
no significant changes in cone b-wave. These findings suggest
that RPE is the primary retinal cell type affected by Prpf
mutations and the photoreceptor dysfunction is secondary to
RPE impairment. Co-transfection of Prpf31 mutant expressing
plasmids with Rho intron 3 minigene led to inhibition of Rho
gene splicing, decreased expression of rhodopsin and apoptosis of
rhodopsin positive retinal cells, corroborating the disturbed pre-
mRNA splicing of retinal functional genes by Prpf31 mutation.
Application of caspase inhibitor Baf substantially improved the
viability of Prpf31 mutant-expressing retinal cells, implicating its
potential therapeutic effect for RP treatment (Yuan et al., 2005).
In a heterozygous knock-in mouse model carrying
Prpf31p.A216P mutation, no photoreceptor cell death or
increased oxidative stress was observed up to 18 months
(Bujakowska et al., 2009; Valdes-Sanchez et al., 2019). In the
wild type RPE cells, most of PRPF31 protein is localized inside
the nucleus, while the mutant PRPF31 displayed cytoplasmic
localization in the form of insoluble aggregates. The wild type
PRPF31 protein was also recruited to the insoluble cytoplasmic
aggregates by the overexpressed PRPF31 mutant protein, thus
depleting it from the nucleus (Valdes-Sanchez et al., 2019). In
this way, the Prpf31p.A216P mutation exerts both dominant-
negative and haploinsufficiency effects, leading to RPE defects.
Prpf31p.A216P/+ knock-in mice display RPE degeneration with
drusen-like deposits, lipofuscin accumulation, vacuolization
of RPE, atrophy of basal infoldings and thickening of Bruch’s
membrane, which resembles the features of age-related macular
degeneration (AMD). A- and b-waves were not affected by Prpf31
mutation, but c-wave defects were observed, which is consistent
with RPE degeneration. Thousand and thirty-three differential
genes were identified in Prpf31A216P/+ mice, including the
chaperone binding proteins. The upregulation of heat shock
protein family A (Hsp70) member 4 like gene (Hspa4l) in the
mutant mice was observed. Moreover, Hspa4l colocalized with
PRPF31 mutant aggregates in the RPE cytoplasm, indicating
activation of the unfolded protein response (UPR) to facilitate
folding of the mutant protein and/or other mis-spliced isoforms.
By alternative splicing analysis, more than 10% of all the genes
were found differentially spliced including Prpf31 itself and genes
involved in retinal degeneration, such as inflammation, oxidative
stress, retinol metabolism (Abca4), ciliogenesis (Bbs1, Bbs4, Bbs5,
Bbs7, Bbs9) and apoptosis.
It is not known why Prpf mutant mice show only RPE
degeneration rather than photoreceptor cell death, which is
the key phenotype of human PRPF-RPs. The higher level of
PRPF31 expression in RPE cells than in the neuroretina may
partly explain the phenomenon (Valdes-Sanchez et al., 2019).
Alternatively, the presence of mutant Prpf31 selectively in the
RPE cells but not in photoreceptors, may confer a dominant
negative response in RPE cells, which is probably more severe
than haplo-insufficiency observed in photoreceptors (Buskin
et al., 2018). More importantly, the phenotypic variation can
be caused by the species difference between mouse and human.
There are fundamental structural and functional differences
between rodent and human retina. The lifespan of mice
may be too short to recapitulate the RP manifestation of
photoreceptor degeneration.
Human iPSC Models
A variety of cell lines have been applied to study the pathological
effects of PRPF mutations, including the widely used ARPE-19 as
a model of native human RPE cell (Dunn et al., 1996). However,
immortalized cell lines do not recapitulate certain in vivo features,
making it difficult to represent the complex in vivo scenario of
RP pathogenesis.
The advent of human induced pluripotent stem cells (hiPSCs)
technology offers a novel strategy for in vitro modeling of human
diseases (Takahashi and Yamanaka, 2006; Takahashi et al., 2007;
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Yu et al., 2007). By transduction of Yamanaka factors Oct3/4,
Sox2, Klf4, c-Myc, patient-derived somatic cells are converted
into pluripotent, embryonic-like state with the capacity of
unlimited self-renewal and multilineage differentiation, enabling
the rapid establishment of disease-specific cell models. These
models are widely used for the studies of disease mechanisms,
toxicological assay, drug screening, and cell replacement
therapies (Artero Castro et al., 2018).
For in vitro modeling of human retinal diseases, it is
important to incorporate the diversity of all retinal cell types
that can be maintained stably in culture for prolonged periods
of time. Several differentiation protocols have been established
for generation of RPE, photoreceptor-like cells as well as retinal
organoids containing all retinal cell types (Lamba et al., 2010;
Kokkinaki et al., 2011; Nakano et al., 2012; Zhong et al., 2014;
Mellough et al., 2015). In our group, an optimized protocol
for retinal organoid differentiation has been created through
statistical design of experiment (DoE) methodology, to efficiently
induce laminated, physiologically functional, and light responsive
retinal organoids on a large scale (Hallam et al., 2018).
For modeling of PRPF-RP, hiPSCs reprogramming from
RP patient fibroblasts carrying PRPF8 missense mutations has
been reported (Lukovic et al., 2017; Foltz et al., 2018). The
established hiPSCs differentiated into RPE cells, showed apical
basal polarity and phagocytosis of POS in the same manner
as wild type cells. Terray et al. (2017) established an induced
pluripotent stem (hiPSC) cell line from dermal fibroblasts of
an asymptomatic patient with dominant PRPF31 mutation.
The reprogrammed hiPSC contained the expected c.709-734dup
substitution in exon 8 of PRPF31, expressed the expected
pluripotency markers, displayed in vivo differentiation potential
to the three germ layers and had normal karyotype, but deeper
studies into RP pathogenesis were not carried out (Terray et al.,
2017). In our previous work, dermal fibroblasts from RP11
patients with PRPF31 c.1115_1125del11 and c.522_527 + 10del
heterozygous mutations were reprogrammed to hiPSCs and
differentiated into RPE and retinal organoids (Buskin et al.,
2018). A combination of molecular, phenotypic, and biochemical
assays showed the RP11-RPE to be the most affected retinal
cell type. Interestingly, the RP11-RPE and photoreceptors, but
not the hiPSCs or fibroblasts, were characterized by a global
spliceosome dysregulation, matching with the retinal specific
phenotype of RP11. The RP-11 RPE cells displayed a variety
of cellular phenotypes ranging from loss of apical – basal
polarity, impaired tight epithelial barrier, shorter and fewer
microvilli, defective phagocytotic function and the presence of
large basal deposits. Ultrastructural analysis revealed that RP11-
photoreceptors had more apoptotic nuclei and stress vacuoles
compared to the controls. RP11 organoids also showed reduced
responses to neurotransmitter GABA suggesting the impaired
neural networks in RP11 patients. Compared to controls,
RP11-RPE and retinal organoids displayed decreased PRPF31
expression and compromised splicing ability. RP11-RPE cells
but not photoreceptors, were characterized by the presence of
mutant PRPF31 transcript, which may indicate a dominant
negative function in these cells and may explain the more severe
phenotype. Both cilia incidence and cilia length were significantly
reduced in RP11 – RPE and photoreceptors. Our work showed
that the splicing of multiple ciliary genes was affected, thus it is
likely that ciliary phenotype is a direct consequence of retinal
specific spliceosome dysregulation. While the role of cilia in
photoreceptors is well-established, recent studies suggest that
cilia function is also important for RPE maturation and function
(May-Simera et al., 2018), hence, cilia abnormalities in both
RP11-RPE and photoreceptors are likely to worsen the primary
cellular phenotypes due to splicing mis regulation.
Using CRISPR/Cas9-mediated gene-editing, the mutation can
be corrected to produce isogenic-matched control hiPSC lines.
Correction via CRISPR/Cas9 genome editing of patient hiPSCs
was carried out and hiPSC-RPE and retinal organoids were used
to investigate if in situ gene editing could ameliorate/reverse
the cellular phenotypes. Indeed, the gene edited hiPSC derived
RPE and photoreceptors were characterized by longer and
more frequent cilia with well-aligned axonemal microtubules
and restored splicing ability. Moreover, the impaired RPE
apical-basal polarity and phagocytic capacity were restored after
CRISPR/Cas9 correction, suggesting that gene editing provides a
promising approach for RP11 treatment.
In summary, all the RP-PRPFs have been investigated
utilizing a variety of modeling systems. Heterozygous Prpf3
knockout mice show no photoreceptor degeneration, while
RPE degenerative abnormalities are induced in Prpf3 mutation
transgenic animals, indicating that RP18 is caused by the
dominant-negative or gain-of-function effect of Prpf3 mutations.
Similar phenotype is observed in Prpf8 mutation transgenic mice.
prpf4 knockdown in zebrafish results in retinal degeneration.
Injection of prpf4p.Pro315Leu and morpholino oligos (MOs)
against prpf4 in zebrafish triggers retinal deformities and
increase of embryo death rate, indicating that mutations of
prpf4 cause RP via haploinsufficiency and dominant-negative
effects. Disruption of PRP6 genes results in yeast lethality.
PRPF6 knockdown in HeLa SS6 cells significantly suppresses
cell growth. However, it is unclear whether PRPF6 mutations
act as haploinsufficient or dominant-negative elements. In
zebrafish, prpf31 knockdown predominantly damages the retinal
photoreceptor outer segments and impairs visual function, which
is deteriorated by AD5 (c.1115_1125 del) mutant RNA injection.
Therefore, both loss-of-function and dominant-negative effects
are involved in the pathogenic process of prpf31 mutations.
Of note, introduction of Prpf31p.Ala216Pro mutation into mice
model has no detrimental effect on the retina, suggesting that
various mutations may have distinct mechanisms. In addition,
all modeling systems have advantages and disadvantages
(Supplementary Table 3). A full investigation and analysis using
multiple models would be a great strategy to gain a thorough
understanding of the mechanisms underlying a certain disease.
IMPACTS OF PRPF MUTATIONS ON RNA
SPLICING AND GENE EXPRESSION
PROFILE
RNA splicing is at the intersection of transcription and
translation, which explicitly controls both transcript abundance
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and diversity. Mutations of spliceosome components can have
trans-acting effects on RNA splicing, leading to aberrant
transcript products and resultant genetic diseases. By microarray
profiling of peripheral blood samples from RP13 patient bearing
the p.H2309R mutation in PRPF8, transcriptome-wide splicing
defects were identified, affecting approximately 20% of exons.
Greater intron inclusion in mature transcripts was observed
in mutant compared to controls. Flanked by long introns, the
differentially spliced exons were shorter than average, AT rich and
located toward the 5′ end of the gene (Korir et al., 2014). PRPF8
protein is involved in both the major U2-dependent splicing
(snRNPs: U1, U2, U4/U6, and U5) and the minor U12-dependent
splicing (snRNPs: U11, U12, U4atac, U5, and U6atac), as opposed
to other pre-mRNA splicing factors that participate in U2-
dependent spliceosome only (Luo et al., 1999), so PRPF8 mutant
may have distinct effects on splicing that are different from
other PRPFs. Consistently, the accumulation of aberrantly spliced
transcripts retaining both U2-and U12-introns was observed
in the zebrafish mutant Cephalophonus (cph) bearing an early
premature STOP codon in prpf8 (Keightley et al., 2013).
In retinal cells generated via the hiPSC differentiation, high
level of transcripts with retained introns and alternative 3′ splice
sites were identified in PRPF31 mutant organoids and RPE cells
(Buskin et al., 2018). The top category of mis-spliced genes
affected by PRPF mutations was pre-mRNA and alternative
mRNA splicing via the spliceosome, including spliceosome
assembly, formation of the U4/U6 snRNP, 3′-end processing of
pre-mRNAs, association of U2 snRNP with pre-mRNA and 5′-
splice site selection (Buskin et al., 2018). These results were
corroborated by molecular analysis of retinas of Prpf31± mouse
model (Buskin et al., 2018) and the human organotypic retinal
cultures with RNAi mediated knockdown of PRPF31, which
also displayed mis-splicing of genes involved in RNA processing
(PRPF3, PRPF8, PRPF4, and PRPF19) (Azizzadeh Pormehr et al.,
2020). In addition to genes encoding spliceosome component
proteins, a substantial decrease in snRNAs including U2, U4, U5,
U6 was also observed in lymphoblast cell lines from RP patients
with mutations in PRPF3, PRPF8, and PRPF31 (Tanackovic et al.,
2011b). These data indicate that disrupted alternative splicing
programs in RP worsen defects in splicing, and in turn disrupt
biological processes outlined below that trigger the unusual
cellular phenotypes observed in RP.
Phototransduction is one of the most predominant groups of
differentially spliced genes associated with retinal function that
are affected by PRPF mutations/depletion. PRPF31 knockdown
in human organotypic retinal cultures caused mis-splicing of
genes involved in phototransduction, including RHO, GNAT1,
GNAT2, ROM1, PDE6A, and PDE6B, all of which have
been linked to inherited retinal diseases (IRDs) (Sakuma
et al., 1995; Kohl et al., 2002; Naeem et al., 2012; Cheng
et al., 2016; Wang et al., 2018; Azizzadeh Pormehr et al.,
2020). RHO has been verified to be the splicing target for
PRPF31 as a major RP-associated gene. The expression of
mutant PRPF31 in primary mouse retinal cells inhibited
RHO splicing, leading to a significant reduction in RHO
expression and cell death (Yuan et al., 2005). Rhodopsin
is a prototypic member of the G-protein-coupled receptor
family mediating phototransduction cascade initiated by the
isomerization of 11-cis-retinal. Loss-of-function RHO mutations
alone are unlikely to cause adRP, instead, gain-of-function and
dominant-negative mutations appear to be the main pathogenic
reasons due to unfolded-protein response, aggregation and
inclusion formation, structural instability etc. (Mendes et al.,
2005). Our previous work revealed exon 21 skipping in PDE6B
in retinal organoids carrying PRPF31 mutations (Buskin et al.,
2018). PDE6 complex controls intracellular cGMP levels by the
hydrolyzation of cGMP in response to light activation and has
a major role in the phototransduction (Qureshi et al., 2018).
The impaired phototransduction due to the mis-splicing of
key functional proteins may represent a critical mechanism
underlying PRPF-RPs.
In line with the decreased cilia length, cilia incidence and cilia
malformation in PRPF31 mutant RPE cells and retinal organoids,
the splicing and expression of important genes related to cilium
assembly, cilium organization, microtubule organizing center
and centrosome were affected by PRPF mutations (Buskin et al.,
2018). Most of the affected genes such as IFT27, BBS4 and ARL6
are critical for cargo recruitment and transportation to support
ciliogenesis and maintenance. The photoreceptor outer segment
is a special subcellular organelle derived from primary cilium
that plays important roles in phototransduction, visual cycle
and RPE phagocytosis (Molday and Moritz, 2015). Mutations
in these primary cilium component genes are associated with
retinal degenerative diseases including RP (Wheway et al., 2014;
Schaefer et al., 2019). Two photoreceptor disk morphogenesis
related genes peripherin (PRPH2) and retinal fascin (FSCN2)
are significantly suppressed by PRPF mutations as well (Mordes
et al., 2007). Both PRPH2 and FSCN2 are also photoreceptor-
specific genes. PRPH2 encodes a cell surface glycoprotein
localized along the rims of rod and cone photoreceptors. As
an adhesion molecule, PRPH2 protein is involved in stabilizing
and compacting the outer segment disks or in preserving
the rim curvature (Travis et al., 1991; Arikawa et al., 1992).
Prph2−/− knockout mice showed complete absence of outer
segment (Chakraborty et al., 2014) and heterozygous mutations
in the PRPH2 gene are a common cause of adRP (Keen and
Inglehearn, 1996). FSCN2 protein is a fascin family member
that crosslinks F-actin into filamentous bundles within dynamic
cell extensions and plays important roles in photoreceptor disk
morphogenesis (Saishin et al., 1997; Tubb et al., 2000). In mice
models carrying Fscn2 mutations of c.208delG or replacement
of exon 1, Fscn2 expression is substantially suppressed, along
with aberrant outer segment disks, progressive photoreceptor
degeneration and depressed rod and cone electroretinograms
(ERGs), indicating that haploinsufficiency of the Fscn2 gene
may impede maintenance and/or elongation of the OS disks,
resulting in photoreceptor degeneration (Yokokura et al., 2005).
The c.208delG mutation in the FSCN2 gene was identified in 14
individuals with adRP from four unrelated Japanese families, and
it cosegregated with the phenotype in all four pedigrees, implying
an association to RP (Wada et al., 2001). However, another study
on Chinese families came to the opposite conclusion, revealing
that the c.208delG mutation has a negative cosegregation with
retinal degeneration and that this mutation was identified in
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normal family members and control subjects (Zhang et al., 2007).
It is unclear whether ethnicity or other factors influence the
sensitivity to this mutation. Further research with a bigger sample
size representing individuals from multiple ethnic backgrounds
may help to address the question. Taken together, mis-splicing
of important genes involved in photoreceptor functions are
most likely to contribute to the multi-faceted PRPF-driven
RP pathogenesis.
Other significantly affected genes in PRPF mutated human
cells include those involved in actin cytoskeleton, axon terminals,
lysosome and endosomal processes, focal adhesion, cell-substrate
junctions, and extracellular matrix organization, signaling
pathways, apoptosis, inflammation, UPR etc. (Supplementary
Table 2). Although these general functions are not directly
related to RP pathogenesis, they may be affected to a greater
extent in the retina due to the more severe dysregulation of
RNA splicing machinery, thereby facilitating the deterioration of
retinal abnormalities and photoreceptor degeneration.
BEYOND RNA SPLICING
In recent years, PRPF function implications beyond RNA splicing
have attracted increased attentions. In the section below, we will
review the role of PRPFs in ciliogenesis, circadian rhythm and
DNA damage and repair (Figure 3).
PRPFs and Ciliogenesis
Photoreceptors contain a primary cilium (known as the
connecting cilium) that plays a critical role in transporting
cargo from inner segment to the outer segments (Adams et al.,
2007). By whole genome siRNA-based reverse genetics screen,
PRPF6, PRPF8, and PRPF31 were identified as candidate genes
involved in biogenesis and/or maintenance of the primary
cilium. Moreover, these PRPF proteins were localized to apical
inner segment, basal body complex and apical connecting
cilium of photoreceptor cells (Johnson and Malicki, 2019).
In accordance, fibroblasts from RP11 families carrying the
heterozygous PRPF31 frame-shift mutation c.1115_1125del
showed significantly shorter and fewer cilia (Wheway et al., 2015).
In RP11-iPSC-derived retinal organoids and RPE cells harboring
two different PRPF31 mutations, both cilia incidence and cilia
length were significantly reduced compared to wild type controls.
Serial block face scanning electron microscopy (SBFSEM)
analysis revealed shorter, abnormal, bulbous cilia with misaligned
microtubules in RP11-RPE cells. By structured illumination
microscopy (SIM) analysis, RP11-RPE were characterized by
mislocalization of IFT88 protein to the ciliary tip and the
transition zone (TZ) proteins CC2D2A and RPGRIP1L were
either entirely excluded from the TZ or mis localized from the
TZ into the ciliary axoneme (Buskin et al., 2018).
Centrosomes are dynamic organelles composed of bound
pair of microtubule-based centrioles, which serve as basal
bodies required for the formation of primary cilia at cell
surface. Two studies of the centrosomal proteome, identified
PRPF6 and PRPF8 as centrosomal proteins (Andersen et al.,
2003; Jakobsen et al., 2011). Mutations in the cilia-centrosomal
protein gens Retinitis Pigmentosa GTPase Regulator (RPGR)
and FAM161A are the major causes of X-linked and arRP
respectively (He et al., 2008; Bandah-Rozenfeld et al., 2010;
Langmann et al., 2010). These findings suggest that, independent
of their nuclear function in splicing, PRPFs could serve as
important cilia component proteins participating in ciliogenesis
and maintenance of photoreceptor outer segment. It is currently
unknown whether their cilia-specific localization relates to their
splicing function, or whether PRPFs have novel functions that
affect cilia formation during retinal ontogenesis.
PRPF and Circadian Rhythm
Circadian rhythm is an endogenous body clock that drives the
oscillation of various physiological functions such as hormone
production, digestion, blood pressure, body temperature etc.
(Patke et al., 2020). The retinal ganglion cells (RGCs) receive
and relay light signal to the circadian pacemaker in the
suprachiasmatic nuclei of the hypothalamus (SCN), which
subsequently transfer phase information to peripheral oscillators.
Circadian rhythms are controlled by autoregulatory transcription
factors including Clock, Bmal1, Per, Cry, Rev-Erb, and Ror that
form positive and negative feedback-loops for the regulating
system (Ko and Takahashi, 2006).
An intrinsic extra-SCN circadian clock system is present in
the retina, which controls many aspects of retinal biological
processes including gene expression, signaling, metabolism,
retinal electrical responses to light, synthesis and secretion of
neurotransmitters, photoreceptor outer segment shedding etc.
(McMahon et al., 2014). Periodic phagocytosis by RPE of spent
POS is one of the most remarkable retinal circadian processes
regulated by circadian oscillator and the daily light-dark cycle
(Grace et al., 1999). Both photoreceptors and RPE cells have
independent circadian oscillators that regulate the rhythm of
renewal, shedding and phagocytosis of POS (Baba et al., 2010; Ko,
2020). In this regard, the circadian clocks of photoreceptors and
RPE must closely synchronize to ensure the efficient clearance
of the spent POS, which is critical for maintaining retinal
health. Retinal cells show extensive expression of core clock
genes such as PER1, BMAL1, CLOCK, CRY1, and CRY2 that
are under circadian control themselves (Tosini and Fukuhara,
2002; Liu et al., 2012; Hiragaki et al., 2014) and are responsible
for the regulation of circadian gene expressions in the retina.
Some important photoreceptor-specific genes are also under
circadian control, such as light-sensitive receptor proteins opsin
and rhodopsin, cyclic nucleotide–gated channels (CNGC), L-type
calcium channels (LTCCs) and retinal Crystallins that act as
chaperone proteins and play critical roles in photoreceptor
protection (Ko, 2020). In Bmal1 knockout mice, a large fraction
of these rhythmic genes showed non-rhythmic expression or
reduced amplitude due to circadian dysregulation, and visual
function and photoreceptor viability were impaired during aging
(Baba et al., 2018a).
Melatonin and Dopamine are two key circadian elements
in the retina that reciprocally antagonize each other (Tosini
et al., 2008) and play an important role in photoreceptor
survival. During the night, photoreceptors release melatonin
that inhibits the release of dopamine by dopaminergic amacrine
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FIGURE 3 | Impacts of PRPF mutations on various biological processes in the retina. RP-related PRPF mutations primarily result in disrupted spliceosome assembly
and defective RNA splicing, leading to subsequent alteration of splicing profile. Many of the affected genes are involved in important retinal functions, including
phototransduction, retinol metabolism and photoreceptor disk, etc. More mis-spliced genes cluster in general biological processes, such as inflammation, apoptosis
cytoskeleton, signalling pathway, etc. Noteworthy, splicing factors are enriched in the top category of mis-spliced genes affected by PRPF mutations, indicating a
feedback loop that deteriorates the RNA splicing defect in retina. Furthermore, emerging evidence suggests that PRPF mutations may contribute to RP development
via mechanisms beyond RNA splicing. The interrupted lines indicate likely direct effects of PRPF mutations on ciliogenesis, circadian rhythm and DNA repair.
cells (DA). During the day, DA-released dopamine prevents
the melatonin synthesis and release from the photoreceptors
(Tosini and Dirden, 2000; Doyle et al., 2002). Melatonin signaling
was shown to impact the viability of photoreceptor via the
MT1 melatonin receptor. In Mti−/− mice, the daily rhythm
of ERG a- and b-wave amplitudes was lacking, and significant
loss of photoreceptor was detected (Baba et al., 2009). On the
other hand, dopamine was reported to play a critical role in
photoreceptor degeneration. In rd mice, a well-established RP
model, antagonists for D1-/D2- dopamine receptors or dopamine
depletion improve photoreceptor survival, while addition of a
dopamine agonist in dopamine-depleted organ cultures induces
photoreceptor degeneration (Ogilvie and Speck, 2002). In line
with the rhythmic secretion of dopamine and melatonin, their
widespread receptors are also under circadian control in the
retina to ensure the integration and coordination of the clock
signal system (Wiechmann and Smith, 2001; Nir et al., 2002; Baba
et al., 2009; Ikegami et al., 2009).
Recent studies have linked mutations in PRPFs to the
circadian dysregulation in retina. Mouse model carrying a
homozygous H2309P mutation in PRPF8 showed a lengthened
period of the circadian wheel-running activity rhythm as well
as dampened daily cycling rhythm of core circadian clock gene
transcripts PER2, Rev-Erbα and TIM in retina (Shakhmantsir
et al., 2020). Likewise, downregulation of PRPF31 in a human
osteosarcoma cells (U2OS) culture model led to circadian period
lengthening, corroborating the regulatory effect of PRPFs on
circadian rhythm. In another study, primary RPE cells from Prpf3
T 494M/T 494M , Prpf8 H2309P/H2309P, and Prpf31± mice displayed
decreased phagocytosis of POS and elongated phagocytic peak
time, suggesting the defective diurnal rhythmicity of phagocytosis
(Farkas et al., 2014). Prpf4 knockdown in Drosophila tim+ clock
neurons led to a significant intron retention in tim mRNA,
decrease of Tim protein level, delayed nuclear accumulation of
Per and Tim and lengthened free-running circadian periods.
Strikingly, clock-specific knockdown of prp3, prp8, and prp31
resulted in lengthening of free-running circadian period and
complete arrhythmicity (Shakhmantsir et al., 2018). The impacts
of PRPF mutations/downregulation on circadian period in
different species suggest that PRPF factors are broad and
evolutionarily conserved circadian regulators.
In our previous work on retinal organoids derived from
PRPF31 mutant iPSCs, intron retention and alternative 5′ splice
sites were identified in the transcripts of circadian gene PER3,
implicating the impacts of RNA mis-splicing on retinal circadian
system (Buskin et al., 2018).
Emerging evidence suggests that circadian disruption is
associated with the development of retinal disorders. RP patients
were found to have increased daytime somnolence, diminished
alertness, and poorer quality with more disturbed night-time
sleep than their normally sighted counterparts, suggesting an
impaired circadian clock (Ionescu et al., 2001). On the flip
side of the story, knockout mice of circadian clock genes
(Bmal1−/−, Per1−/−, and Per2−/−) show reduced photoreceptor
viability during aging and scattered retinal deformation by
fundus inspection (Bunger et al., 2000; Ait-Hmyed et al., 2013;
Baba et al., 2018b). Furthermore, Rev-Erba−/− mice showed
increased light sensitivity, represented by shortened latencies
of both ERG a- and b-wave, modified scotopic and photopic
b-wave and scotopic threshold responses, and increased pupillary
constriction (Ait-Hmyed Hakkari et al., 2016). Together these
reports indicate a close link between photoreceptor viability and
regulation of circadian rhythm. PRPFs may be implicated in
these synergistic regulations by way of regulating the splicing of
circadian clock genes, however, a secondary impact on circadian
clock genes as result of overall retinal degeneration caused by
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PRPF mutations cannot be excluded. A deeper exploration of
the hypothesized PRPFs-circadian system-RP model may provide
a novel view to understand the mechanisms underlying PRPF
mutation-associated RP.
PRPFs and DNA Damage Repair
As a light sensor, the retina is constantly exposed to ultraviolet
radiation. During the vertebrate visual cycle, 11-cis-retinal
bleaching by light leads to the generation of free radical and
oxidative stress (Roehlecke et al., 2009, 2011; Organisciak and
Vaughan, 2010; Punzo et al., 2012; Kiser et al., 2014; Geiger
et al., 2015). Retina is one of the most metabolically active tissues,
which implies greater oxidative harm by reactive oxygen species
(ROS), a natural by-product of mitochondrial metabolism.
Oxidative stress and metabolic dysregulation have been proposed
to be associated with retinal degeneration and vision loss (Shen
et al., 2005; Punzo et al., 2012) and increased oxidative damage to
proteins, lipids and DNA by ROS was found during the course of
RP (Domènech and Marfany, 2020).
Maintaining genomic integrity is important for proper cell
function and the fidelity of genome transfer to progeny. However,
DNA can be damaged by environmental factors such as UV light,
ionizing radiation, and endogenous metabolic products such as
ROS. DNA lesions caused by detrimental factors comprise single
strand break (SSB), double strand break (DSB), intra- and inter-
strand cross-links, and DNA adducts etc. Cells have evolved an
elaborate DNA damage response (DDR) system to deal with
the fundamental problem of genomic erosion, including DNA
repair, chromatin remodeling, replication, cell cycle checkpoint,
damage tolerance, energy control, and programmed cell death.
Three PI3-kinase protein kinases – ATM (Ataxia Telangiectasia
mutated), ATR (ATM related), and DNA PK (DNA-dependent
protein kinase) are at the mammalian DDR apex (Kolodner
et al., 2002; Harper and Elledge, 2007; Menolfi and Zha, 2020).
DSBs are primarily sensed by the MRN complex (consisting of
Mre11, Rad50, and Nbs1) that recruits ATM to the DNA damage
sites. RPA binds to single strand DNA and recruits ATR via its
association with ATRIP. The activated ATM/ATR kinases activate
other kinases, including CHK1 and CHK2 (Ciccia and Elledge,
2010). Ku70/80 is another DSB sensor that recruits DNA-PK,
which plays important roles in non-homologous end joining
(NHEJ), telomere maintenance and induction of apoptosis. Three
basic DSB repair mechanisms exist: homologous recombination-
mediated DNA repair (HR), NHEJ, and single-strand annealing.
Emerging evidence has shown an important role for RNA
splicing factors in the cellular response to DNA damage.
By genome-wide siRNA screening, hundreds of genes were
identified, whose down-regulation led to increased DNA damage,
as monitored by the phosphorylation of H2AX (γH2AX), an
early mark of DNA damage (Jimeno et al., 2002). Notably, genes
involved in mRNA processing represented the most significantly
enriched category, including PRPF3, PRPF4, PRPF8, PRPF31,
PRPF19, SART1, SF3A1 etc. Consistently, knockdown of most
splicing factors induced a significant increase in cells with
multiple 53BP1 foci. Knockdown of splicing factors CDC40 and
SKIIP also caused a defective G2/M checkpoint in response to
DNA damage (Paulsen et al., 2009).
RNA splicing machinery responds to DNA damage at
multiple levels including splicing of DNA repair genes, DNA
damage recognition, signaling and repair, RNA-DNA hybrid
formation and genome stability etc. (Wickramasinghe and
Venkitaraman, 2016). In prpf31 knockout zebrafish, retinal
progenitor cells (RPCs) displayed significant mitotic arrest and
DNA damage, which was rescued by the wild type human
PRPF31. Bioinformatic analysis revealed that deletion of prpf31
primarily caused the skipping of exons with a weak 5′ splicing
site. Moreover differentially spliced genes were predominantly
enriched in GO categories of DNA repair and mitotic progression
(Li et al., 2021). This is consistent with our findings in Prpf31±
mouse retina (Buskin et al., 2018) and suggests that PRPFs may
affect DDR via splicing of important genes implicated in DNA
repair and cell cycle regulation.
The post-translational modifications of splicing factors have
been correlated with DDR, reflecting the initial steps of a
concerted process that coordinates the response of RNA splicing
to DNA damage. Following HEK 293 cell treatment with ionizing
radiation (IR), more than 700 proteins became phosphorylated
at ATM/ATR consensus sites. Splicing factors PRPF3, PRPF4,
and SART3 were included in the list, suggesting that they
were targets for the DDR kinases (Matsuoka et al., 2007).
Proteomics analysis of site-specific phosphorylation changes
of nuclear proteins after ionizing radiation in B-lymphocyte
cells also revealed dephosphorylation of PRPF4 on 18 sites,
indicating the importance of controlling RNA processing at
the onset of the DDR (Bennetzen et al., 2010). Prp19 complex
(Prp19C) or NineTeen Complex (NTC), is a crucial component
of spliceosomes that regulates the formation of U4/U6.U5 tri-
snRNP complex and is involved in shaping the active site of
the spliceosome (Hogg et al., 2010; Song et al., 2010; Fica
and Nagai, 2017). Human Prp19C consists of the U-box E3
ligase Prp19 homotetramer complex, CDC5L, SPF27, PRL1,
CTNNBL1, AD002, and Hsp73. Upon DNA damage, Prp19C
acts as a sensor of DNA damage and directly binds RPA bound
to ssDNA, then ubiquitylates RPA to trigger the recruitment of
ATRIP and activation of ATR(Marechal et al., 2014; Shkreta and
Chabot, 2015; de Moura et al., 2018).
During transcription, newly transcribed RNA anneals to the
negatively supercoiled DNA to form a stable RNA–DNA hybrid
structure known as R-loop. The exposed non-transcribed single-
strand DNA is vulnerable to DNA damage. Deficiency in RNA
splicing or defects in mRNA biogenesis can lead to increased
R-loop formation and subsequent DNA breaks, transcription and
replication stall, and genomic instability (Wongsurawat et al.,
2012). In PRPF31 knockdown RPE-1 cells and primary cells from
the stromal vascular fraction (SVF) of Prpf31-deficient mouse
models (Prpf31± and Prpf31+/A216P), significantly increased
γH2AX and 53BP1 foci were observed. These were decreased
upon overexpression of active RNaseH1, indicating the role of
R-loops in genomic instability caused by Prpf31 depletion (Bhatia
et al., 2018). Prp19C is involved in the transcription-coupled
repair (TCR) pathway, recruiting the THO/TREX complex to
transcribed genes, which is important to prevent the formation
of R-loops and genome instability (Chanarat et al., 2011).
In accordance with this, PRP19 mutant S. cerevisiae display
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increased sensitivity to the DNA damaging reagent psoralen as
well as other inter-strand cross-link (ICL) inducing reagents
(Henriques et al., 1989). In human MRC5 and Hela cells, PRP19
is significantly up-regulated in response to DNA damage and
PRP19 knockdown results in accumulation of double-strand
breaks (DSBs), apoptosis and decreased cell survival after DNA
damage induced by γ-radiation (Mahajan and Mitchell, 2003).
RNA splicing is essential for the homologous recombination
(HR) repair of chromosomal breaks, which is critical for the
stability of the genome. Genome-wide screening studies have
revealed the importance of RNA splicing factors (e.g., RBMX
and U2 snRNP factor SNRPA1) as positive regulators of HR
(Adamson et al., 2012; Tanikawa et al., 2016). To evaluate the
influence of the RNA splicing factor PRPF8 on HR, U2OS cells
were treated with siPRPF8 and specific defect in homology-
directed repair (HDR), single strand annealing (SSA) and end
resection as well as R-loop accumulation were observed. PRPF8
knockdown caused a significant reduction in foci of DNA repair
protein BRCA1, indicating that PRPF8 protein is important
for BRCA1 foci formation. Depletion of p53-binding protein
1 (53BP1) suppressed the HR defect induced by both BRCA1
loss and PRPF8 knockdown, suggesting that PRPF8 functions
during HR at least in part via facilitating BRCA1 function
(Onyango et al., 2017).
The retina-specific intensive oxidative stress associated DNA
damage and the essential role of RNA splicing factors in
DNA repair and maintaining genome stability indicate that the
compromised DNA repair machinery due to PRPF mutation in
RP may not be sufficient to meet the high demand in retina, hence
leading to genome instability and retinal degeneration. Together,
the roles of PRPFs in ciliogenesis/outer segment shedding,
circadian rhythm, and DNA damage repair, indicate their critical
functions beyond mRNA processing which may or may not be
linked directly to PRPF’s role in splicing, offering new insight into
the pathway of PRPF-RP pathogenesis.
THERAPEUTIC STRATEGIES FOR
PRPF-RP
To date there is no cure for RP and therapeutic options
are limited. Aside from reduction in light exposure, dietetic
interventions have been proposed to benefit RP patients, slowing
disease progression (Scholl et al., 2016). For example, RP patients
taking high dosage vitamin A showed slowed declines in ERG
amplitudes and delayed loss of visual field. Accordingly, daily
intake of vitamin A is recommended to adults with RP in
the early- or mid-stages (Miggiano and Falsini, 2004). In non-
smoking RP patients taking vitamin A, supplementation with
lutein 12 mg per day reduced midperipheral visual field deficit
on average (Berson et al., 2010). Individuals with the highest
DHA (Docosahexaenoic acid) levels in red blood cells displayed
the slowest rate of retinal degeneration and people having DHA
supplemented diet (1.4 g per week) showed a 40–50% slower
visual field loss compared to controls (Berson et al., 1993).
In an open-label prospective, phase 1b trial, Leber congenital
amaurosis (LCA) patients (aged 6–38 years) with RPE65 or LRAT
mutations were given oral QLT091001 (synthetic 9-cis-retinyl
acetate) for two years and improvement in GVF (Goldmann
visual field) areas and visual acuity was observed (Koenekoop
et al., 2014). Antioxidants have been reported to reduce oxidative
damage to photoreceptors and preserve retinal function in RP
models (Komeima et al., 2006). N-acetylcysteine amide (NACA)
is a potent thiol antioxidant to protect RPE and photoreceptors
from oxidative stress by increasing glutathione peroxidase and
scavenging ROS (Schimel et al., 2011). Fort Worth-based Nacuity
Pharmaceuticals is launching a Phase I/II clinical trial in Australia
for NACA oral therapy aiming to slow vision loss in RP patients.
Despite the beneficial effects, these supplements can only play
protective roles to a certain extent, but do not constitute a real
remedy to RP cure. Since PRPF-RPs are monogenic IRDs, recent
studies have focused primarily on gene-based therapies to rectify
PRPF mutation-associated abnormalities, which we discuss as
follows:
Augmentation of Normal PRPF
Expression Level
Haploinsufficiency is a major underlying cause in human RP
patients carrying PRPF31 mutations and the severity of RP
is related to the variant expression level of remaining wild
type PRPF31, thus, gene augmentation is a suitable therapeutic
approach for this condition (Rivolta et al., 2006). Recent work
has indicated that RPE cells derived from PRPF31-RP patients
were characterized by decreased PRPF31 expression and defects
in ciliogenesis, reduced cell barrier and phagocytosis (Buskin
et al., 2018). When these cells were treated with adeno-associated
virus (AAV)-PRPF31 to supplement the expression of wild type
PRPF31, aberrant morphological and functional phenotypes were
restored, as indicated by increased cilia length and incidence,
elevated Transepithelial Electrical Resistance (TER) level, rescued
phagocytosis, decreased stress vacuoles and restored collagen IV
expression level and pattern in basal lamina (Brydon et al., 2019).
These findings indicate that for patients with PRPF31-related
RP, AAV-based gene augmentation strategy targeting RPE cells
holds therapeutic promise. As a single stranded DNA parvovirus,
AAV is currently the most attractive vector for gene therapy
with benefits including high gene transfer efficiency, stable long-
term expression, non-genome integration, low immunogenicity,
transduction of both mitotic and postmitotic cells and no
pathogenicity to humans (Oner, 2017; Kimura et al., 2019).
Several AAV-based vectors have been employed for clinical trials
treating retinal diseases such as RP, Usher syndrome, Stargardt
disease etc. (Ong et al., 2019). Recently, great progress has been
achieved in this field with the approval of LUXTURNATM by
FDA for the gene therapy of LCA, RPE65 mutation-associated
retinal dystrophy (Darrow, 2019). While no clinical trial has been
reported for PRPF-related mutation RP gene therapy, it is fair
to expect such therapeutic regimens to occur in the not-too-
distant future. A major limitation of AAV vector is a relatively
small packaging capacity (∼4.7 kb) (Grieger and Samulski, 2005),
which is suitable for the transfer of PRPF3 (2 kb), PRPF4
(1.6 kb), PRPF6 (2.8 kb), PRPF31 (1.5 kb) but not PRPF8 (7 kb).
Nanoparticles have emerged as a promising technology for gene
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transfer owing to the possession of all AAV merits plus unlimited
DNA size (Yanik et al., 2017), making it an ideal alternative vector
when it comes to the transfer of large genes.
PRPF31-associated adRP features strikingly incomplete
penetrance, whereby individual mutation carriers in the affected
family exhibit RP symptomatic or asymptomatic (Vithana et al.,
2003). The asymptomatic cases have been closely linked to a
higher expression of the wild type PRPF31 allele, implying a
particular transcription regulating machinery to compensate
for the mutant allele (McGee et al., 1997; Rivolta et al., 2006).
Interestingly, CNOT3 gene that lies near PRPF31 locus (19q13.4)
has shown a significant inverse relationship with PRPF31
expression. CNOT3 knockdown led to an increase in PRPF31
expression and chromatin immunoprecipitation verified the
directly binding of CNOT3 protein to a specific PRPF31
promoter sequence, indicating that CNOT3 acted as a repressive
trans-acting factor to regulate PRPF31 expression (Venturini
et al., 2012). The clinical appearance of RP11 tends to be
determined by the coinheritance of a heterozygous PRPF31
mutation and a homozygous higher expressivity variant of
CNOT3 (Rose et al., 2014).
Upstream to the transcription start site (TSS) of PRPF31
gene, a cluster of MSR1 elements was identified that acts as a
cis regulatory element to modulate PRPF31 promoter activity.
MSR1 element copy number variation (CNV) regulates the
PRPF31 gene expression, thereby controlling the phenotypic
incomplete penetrance in PRPF31-associated adRP (Rose et al.,
2016). A 3-copy repeat allele dramatically quenched gene
expression in vitro. PRPF31 mutation carriers bearing 4-copy
repeat MSR1 allele displayed a strong PRPF31 expression and
were asymptomatic. The determination of PRPF31 expression
and RP penetrance by MSR1 copy number suggests that this
element might be a candidate regulator for a novel “natural
gene therapy.” By linkage analysis, another two trans-acting
expression quantitative trait loci (eQTL) were established that
were strongly related to PRPF31 expression variation. One of
them was located to 19q13.4 that is close to PRPF31 gene on
the wild type allele (McGee et al., 1997). Another one was
mapped to chromosome region14q22.1–23.1 that functions as
the RP11-distant regulator (Rio Frio et al., 2008). These findings
elicit a novel idea that PRPF31 expression can be enhanced by
modulation of its regulatory factors and/or elements, thereby
alleviating RP manifestation.
Emerging evidence indicates that most autosomal dominant
disorders are mutationally heterogeneous. In addition to
haploinsufficiency, gain-of-function or dominant-negative effects
contribute to PRPF-RPs as well (Supplementary Table 1).
Under such circumstances, gene supplementation therapy alone
would not be sufficient to restore RP defects. To eliminate
the interference of wild type PRPF functions by the mutant
protein, specific nullification of the mutant allele in conjunction
with gene supplementation may provide a more effective
approach (Diakatou et al., 2019). In severe adRP rat model
carrying rhodopsin gene S334ter mutation (RhoS334), selective
cleavage of RhoS334 site by CRISPR/Cas9 was successfully
performed to disrupt the dominant-negative allele and ablate
the toxic effects of the mutation, leading to preserved POS
structure, enhanced photoreceptor survival and improved visual
acuity (Bakondi et al., 2016). Another option is to suppress
both the mutant and wild type alleles of a target gene and
to supply a replacement gene concurrently, which codes for
wild protein but is resistant to suppression due to sequence
changes at degenerate sites. In a transgenic mouse model
bearing human RHO Pro347Ser mutation, AAVshQ1-mediated
suppression of human RHO in combination with replacement
with the endogenous mouse gene significantly delayed the retinal
degeneration, demonstrated by photoreceptor preservation and
improved ERG (Chadderton et al., 2009). The suppression-
and-replacement strategy helps to overcome the mutational
heterogeneity present in PRPF-adRPs and provides an alternative
regiment for prospective clinical practice.
Gene Editing for Correction of PRPF
Mutations
A significant downside of gene supplementation therapy for
retinal degenerative diseases is the limited effective period in
which the vision gains decline over time (Bainbridge et al.,
2015; DiCarlo et al., 2018). In this respect, direct correction
of the original mutations by gene editing will be more
advantageous. Several sequence specific endonuclease systems
have been developed for HDR-based gene editing, including
Meganucleases, zinc finger nucleases (ZFN), transcription
activator-like effector nucleases (TALEN) and clustered regularly
interspaced short palindromic repeats (CRISPR/Cas9) (Peng
et al., 2017; Yanik et al., 2017).
As mentioned above, we used CRISPR/Cas9 to correct
PRPF31 c.1115_1125del11 mutation in RP11-iPSCs and observed
morphology and function restorations in the corrected iPSC-
derived photoreceptors and RPE, showing rescued ciliogenesis,
phagocytosis and apical-basal polarity, which provided proof
of concept for potential therapeutic strategies (Buskin et al.,
2018). These in vitro gene editing results also point to a
promising prospect of in vivo correction of PRPF31 mutations
using the CRISPR/Cas9 system. Some work has recently been
performed on other IRDs. Autosomal recessive mutation of
RPE65 is the main cause of LCA that leads to childhood-
onset blindness. With subretinal injection of CRISPR/Cas9 AAV
vector into rd12 LCA mice model, >1% mutation homology-
directed repair was achieved and photoreceptor light response
was partly rescued (Jo et al., 2019). To restore vision loss in
another Leber congenital amaurosis type 10 (LCA10) associated
with CEP290 gene mutations, Maeder et al. (2019) developed a
CRISPR/Cas9 therapeutic that efficiently corrected the mutant
alleles in humanized mice and primate cells in vivo. Recently,
this therapeutic approach was approved by FDA for the first
phase I/II clinical trial in LCA10 patients, which set the milestone
for the treatment of IRDs using the CRISPR/Cas9 tool and
kick start the era of genome surgery. Although no in vivo
CRISPR/Cas9 studies on PRPF mutation related RPs have been
documented at this time, it is conceivable that such therapeutics
are underway. An interesting phenomenon is that most PRPF8
mutations identified cluster in a highly conserved region within
the last exon, suggesting that a possible common CRISPR system
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might be applicable for the correction of all PRPF8 mutations
(Mordes et al., 2006).
Although significant advances have been made, challenges
must be overcome to enable therapeutic use of CRISPR-Cas9
in vivo, including vehicle delivery, targeting efficiency, error-
prone non-homology end joining (NHEJ), off-targeting etc.
(Burnight et al., 2018). More studies are warranted to improve
the efficiency, accuracy, and safety of gene editing therapies.
Other Therapies Independent of
Mutation
Gene therapy holds great promise in the treatment of RP, but
in most cases, it can only be directed to a specific mutation
or a single gene, making it costly and difficult for therapeutic
translation. In this regard, generalized therapies suitable for a
broad spectrum of retinal degenerative disorders independent of
mutation intervention would be welcome for clinical practice.
Rod photoreceptor is the primary affected photoreceptor
cell type in RP development followed by secondary cone
degeneration. Photoreceptor transcription factor Nrl functions
as a cell fate switch favoring rod development against cone
(Mears et al., 2001). With Nrl knockout in Pde6brd1/rd1 and
Rho−/− RP mice models, the RP-sensitive rod photoreceptors
were reprogrammed into cone-like cells that are resistant to
mutation effects and retinal degeneration was substantially
suppressed (Montana et al., 2013). Similar results were achieved
in another study with two RP animal models rd10 and FVB/N in
which CRISPR/Cas9-mediated Nrl inactivation reprogrammed
rods into cone-like photoreceptors (Zhu et al., 2017). Along
with the in vivo rod-to-cone switch, retinal tissue integrity was
preserved, and function was significantly improved. Moreover,
the retinal rod and cone degeneration were rescued, the
outer nuclear layer thickness was improved and the photopic
b-wave value increased. These studies showed the therapeutic
potential of in vivo cell reprogramming in protection of
photoreceptors from RP damage and maintenance of retinal
function. In addition, the beneficial effects in various RP
animal models implicate the universal application of this
novel approach in treating RP in a gene- and mutation-
independent manner.
The effects of neuroprotective strategies, as compared to
gene- or mutation-specific interventions, are not dependent on
individual mutations and give a longer care window. In RP
animal models and clinical trials for the treatment of geographic
atrophy (GA), Neurotrophic Factor (CNTF) has been shown to
be highly protective against photoreceptor degradation (Liang
et al., 2001; Tao et al., 2002; Zhang et al., 2011). Intravitreal
application of rAAV2/2.hCNTF into the Rho−/− RP mice
model dramatically promoted the survival rate of cone and
preserved visual function. Since PRPF31 mutation leads to
the downregulation of RHO expression (Yuan et al., 2005),
CNTF supplementation might be worth investigating in the
treatment of PRPF-RP.
Injection of rod-derived cone viability factor (RdCVF) into
P23H rat RP model with Rhodopsin mutation decreased cone
loss and substantially preserved their function (Yang et al.,
2009). Several other neuroprotective neurotrophic factors have
shown beneficial effects in RP models, such as brain-derived
neurotrophic factor (BDNF), basic fibroblast growth factor
(bFGF), pigment epithelium–derived factor (PEDF), and glial
cell–derived growth factor (GDNF) (McGee Sanftner et al., 2001;
Scholl et al., 2016). Autologous platelet-rich plasma (APRP)
contains numerous growth factors (Lubkowska et al., 2012) and
subtenon-injection of APRP has been approved for clinical trial
for the treatment of RP.
Cell replacement therapy using hiPSC-derived retinal
photoreceptor precursors has attracted more and more endeavor
for restoration of visual function in RP (Li et al., 2012). In RP
animal models, transplanted photoreceptor precursor cells were
able to integrate into host retina, re-establish outer nuclear layer
and restore visual function (MacLaren et al., 2006; Singh et al.,
2013). Phase I/II clinical trials of stem cell based RPE and fetal
RPCs have been approved by FDA (Uy et al., 2013; Singh et al.,
2020), encouraging great improvement in stem cell therapeutics
for the treatment of RP.
CONCLUSION
RP-associated PRPF proteins (PRPF3, 4, 6, 8, 31 and SNRNP200)
are essential components of U4/U6 and U5 snRNPs, which
combine to form tri-snRNPs. Through protein-protein and
protein-snRNA interactions, PRPFs play critical roles in the
assembly and stabilization of spliceosome, which is essential for
RNA splicing. In adRP families, a variety of PRPF mutations
have been identified, leading to impaired spliceosome assembly,
and compromised splicing efficiency. Compared to human RP11-
iPSCs and fibroblasts, RP11-RPE and retinal organoids show
the most significant enrichment of differentially spliced genes
in GO biological processes of pre-mRNA and alternative mRNA
splicing, which is also corroborated by the differential exon usage
analyses of Prpf31± mouse retinae and RPE. The preferential
tissue disruption of alternative splicing programs leads to a feed-
back loop that exacerbates the splicing deficiencies in retina.
In line with the defective splicing machinery, a wide spectrum
of mis-splicing and dysregulated genes has been identified in
PRPF-RP retinal cells, including a variety of retina-specific genes
involved in photoreceptor development and functions such as
phototransduction, ciliogenesis, retinol metabolism and some
involved in generic functions including UPR, cell adhesion and
migration, apoptosis etc.
Apart from the essential role of PRPFs in pre-mRNA
processing, recent studies have implicated their possible
functions beyond RNA splicing. PRPF proteins were found
localized to apical inner segment, basal body complex and
apical connecting cilium of photoreceptor cells and PRPF31
mutation have been associated with defective ciliogenesis in
RPE and retinal organoids, suggesting that PRPFs may function
as important cilia component proteins to take part in retinal
development and structural maintenance. Multiple aspects of
retinal biological processes are under the regulation of circadian
rhythm. Primary RPE cells from Prpf mutant mice displayed
impaired diurnal rhythmicity of phagocytosis and Prpf31
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mutation led to circadian gene mis-splicing in retinal organoids,
indicating a role for PRPFs in retinal circadian regulation.
The retina is constantly exposed to exogenous radiation and
endogenous ROS; therefore, an intact DNA damage repair
system is essential for maintaining genome stability in retinal
cells. Various aspects of DNA damage response have been
reported to correlate with PRPF functions, including DNA
damage recognition, prevention of the R-loop formation and
DNA damage repair. Downregulation of PRPFs induces defective
DNA damage repair and accumulation of R-loop in various cell
types including RPE.
The PRPF functions beyond RNA splicing provide novel
angles to investigate the pathogenesis of PRPF-RP. A thorough
understanding of PRPF functions in the retina would help solve
the riddle of PRPF-RP ontology and inspire the establishment
of novel therapeutic strategies. Gene supplementation and
CRISPR/Cas9-based gene correction have been tested in
PRPF-RP patient-derived retinal cells with excellent outcomes,
suggesting that these therapies are viable approaches for
the treatment of PRPF-RPs. A plethora of progress has
been obtained in experimental studies or clinical trials on
RP regiments, such as neuroprotective factors, in vivo cell
reprogramming, cell replacement therapy, antioxidants etc.
The combination of these mutation-independent methods with
mutation-specific gene approaches may provide the platform
for the clinical trials that would potentially benefit PRPF-
RP patients.
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